Abiopharma

🔍 Lev Joshua S. (Executive)

Company: electroCore, Inc. (ECOR)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 45,000 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 94,556.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents a grant of Restricted Stock Units (RSUs) of the Issuer. The grant vests in full on December 31, 2026, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (ii) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.
• F2: Includes 12,556 shares of Common Stock, and 37,000 shares of Common Stock issuable pursuant to previously issued RSUs, comprised of: (i) 6,667 shares, of which (a) 3,333 shares will vest on January 15, 2027 and (b) 3,334 shares will vest on January 15, 2028; (ii) 5,333 shares, which will vest on January 12, 2027; and (iii) 25,000 shares, of which (a) 8,333 shares will vest on January 26, 2027 and January 26, 2028, and (b) 8,334 shares will vest on January 26, 2029; provided that (x) the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (y) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.